Some serious investors down serious amounts now. Which major...

Some serious investors down serious amounts now.

Which major backers are winning with PAB?

Even brokers took shares in place of fees at 5 cents.

I wonder why?

Its not a bad announcement, it just could have been better.

Maybe the Onyx budget changed.

Share price pointed to this conclusion months ago.

Can never ignore or go against the market.

Its just so hard to pick if a small cap speculative stock has investor interest at the core or if directors have their enormous salary/hobby as first priority.

From the last 12 patient trial "On average each patient had received five prior lines of therapy, including
proteasome inhibitors, immunomodulatory (IMID) drugs or stem cell transplantation".

From today "who are refractory and/or intolerant to bortezomib, a currently-marketed proteasome inhibitor"

This trial should provide access to people less advanced in their disease so hopefully the chance of a response to the disease in combination will be much higher.


Data coming out of France soon may show some positive results from a lab environment with SM6 in combination with the major MM drugs.